Sildenafil Tablet, Film Coated
Product Images NDC 76420-061

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 76420-061). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Asclemed Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

20mg-30s (Sildenafil 20mg 30s)

Description: Sildenafil Tablets, USP 20mg is a medication manufactured by Macleods Pharma USA Inc. It comes in a package of 30 tablets with each tablet containing 20mg of the active ingredient sildenafil. The tablets are round, white, film-coated, and have "C 69" imprinted on them. The NDC code for this medication is 76420-061-30 and the source NDC is 33342.121-10. This medication is commonly used to treat erectile dysfunction (ED) in men.*

FDA Label Image

20mg-90's (Sildenafil 20mg 90s)

Description: Rolabood By Enovachem is a medication presented in tablets of 20mg and with NDC code 76420-061-90. The lot number is 000000, and the expiration date is 001000000 10000000. It should be stored at 25-27°C (77°F) in a controlled room temperature and kept out of the reach of children. The drug stats indicate it is available only through prescription (RX).*

FDA Label Image

Figure-10 (Sildenafil Fig 10)

Not available. The text seems to be a random set of letters, numbers and symbols that do not form a coherent description of anything in particular. It is likely that the was not able to accurately detect and transcribe the original text.*

FDA Label Image

Figure-11 (Sildenafil Fig 11)

FDA Label Image

Fig-12 (Sildenafil Fig 12)

FDA Label Image

Fig-6 (Sildenafil Fig 6)

FDA Label Image

Fig-8 (Sildenafil Fig 8)

The text appears to be a chart or table showing the fold change and recommendations for different drugs, along with the dosage adjustment required when interacting with other drugs. The chart also includes some values related to the relative change of certain drugs and a note regarding the effects of Ritonavir on Sidenafil PK.*

FDA Label Image

Figure-9 (Sildenafil Fig 9)

FDA Label Image

Figure-7 (Sildenafil Figure 7)

This text appears to be a table or a chart featuring different drugs and their impact on AUC and Cmax. The chart indicates that some drugs do not require a dose adjustment when taken with others, while some require monitoring when co-administered. The chart also shows the relative changes in AUC accumulation ratio from day 10 to day 7 when compared to taking sildenafil alone. The text mentions clinical studies but does not provide any further specific details.*

FDA Label Image

Str (Sildenafil Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.